Market Overview

Rodman & Renshaw Maintains Market Outperform Rating and $5 PT on AMR


A report from Rodman & Renshaw reiterates its Market Outperform rating and $5 price target on AMR Corp. (NYSE: AMR).

The report states, “Over the weekend, the APA released a negotiations update which indicated that “no future meetings with the company are scheduled.” It's unclear why a schedule for fast pace negotiations wasn't settled & mgmt provided no further comment. The stalemate comes after both sides had indicated in mid-November that a deal was potentially days away.”

AMR closed Friday at $1.61.

Posted-In: Rodman & RenshawAnalyst Color Reiteration Pre-Market Outlook Analyst Ratings


Related Articles (AMR)

View Comments and Join the Discussion!

TransAtlantic Petroleum Provides Update on Operations at Selmo Field

Prana Secures Key Patent for Parkinson's Drug PBT434 in the United States